Postprandial effects of almond lipids on cardiovascular risk factors

Not Applicable

• Conditions: Postprandial effects of almond lipids on cardiovascular risk factors; Cardiovascular - Normal development and function of the cardiovascular system

• Registration Number: ACTRN12612000856819
• Lead Sponsor: Riddet Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Healthy male or female.
Are aged between 18-65 years at initial assessment.

Exclusion Criteria

Currently on cholesterol lowering drugs
Currently on non-steroidal anti-inflammatory drugs
Currently on weight loss program
Have a body mass index (BMI) higher than 30
Diagnosed with any gastrointestinal disorder
Diabetes
Pregnancy or lactation
Allergic to nuts, particularly almonds

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of this project is to examine the effects of matrix in which almond lipids are complexed on postprandial lipid levels, inflammation markers, and satiety hormones. <br>The primary outcome measured are the changes in lipids[At each of the 4 intervention sessions, blood will be collected and these biomarkers measured at baseline, 1.5, 2.0, 2.5, 3.0, 3.5, 5.0 and 6.0 hours after treatment.]

Secondary Outcome Measures

Name	Time	Method
The secondary outcome measured are the changes in inflammatory biomarkers (Human C reactive protein<br>Tumour necrosis factor-aplha, Interleukin-6)[At each of the 4 intervention sessions, blood will be collected and these biomarkers measured at baseline, 1.5, 2.0, 2.5, 3.0, 3.5, 5.0 and 6.0 hours after treatment.]